About

Tyler Nolan Trexler is a four-time survivor of Ewing Sarcoma. His journey is not defined by the cancer he has battled since age 17 but by the unshakable determination with which he has faced every challenge. He is the embodiment of strength, perseverance, and purpose.

Tyler was first diagnosed during his senior year of high school—a time typically marked by celebration and anticipation. Instead of surrendering to fear, he graduated high school with honors and remained active in basketball, the sport he loves, both as a player and a coach.

When cancer returned during his sophomore year at UNC Chapel Hill, Tyler remained undeterred. He continued his studies through a difficult treatment schedule and was determined to embrace every opportunity that came his way including studying abroad at the Copenhagen Business School the following summer.  A year later, just as he began a consulting internship in Washington, D.C., the cancer returned for a third time. While yet again undergoing chemotherapy and proton radiation, he juggled a full-time internship and his final year of college. In May of 2024 Tyler graduated from the UNC Kenan-Flagler Business School, an achievement that reflects his extraordinary resolve.

Through it all, Tyler has turned pain into purpose. He has raised funds for Duke Children’s Hospital through UNC and Sigma Nu fraternity sponsored events. He even rappelled down a 22-story building in Durham to support the Children’s Hospital’s “Over the Edge” campaign and he continues to support that mission today. After graduating from college, Tyler accepted a position at Siemens Energy in their sales and marketing development program and once again today is facing yet another recurrence of Ewing Sarcoma.

The TNT Strong Foundation is a tribute to the community that has supported Tyler throughout his journey—the doctors, PAs, nurses, researchers, coaches, teachers, family, and friends. The Foundation was launched to channel Tyler’s resilience into impact, to offer empathy, to offer hope, and most importantly to find a cure for those stricken by this pediatric cancer.